Skip to main content
Premium Trial:

Request an Annual Quote

Scienion, Genomica Jointly Developing Printing Technology for Molecular Applications

NEW YORK (GenomeWeb News) – Scienion and Genomica Unipersonal today said they are expanding their partnership to offer a jointly developed printing plate technology platform that combines each firm's technology.

The new platform integrates Scienion's non-contact arraying surface technologies with Genomica's multiplex PCR technology and microarray technology, resulting in the advancement of new molecular applications, the companies said. They added they will offer services to the microarray space based on the new technology. These new services will range from assay development to microarray manufacturing.

Scienion CEO Holger Eickhoff said in a statement that the combination of the companies' technologies is a "perfect match. We are aiming to speed up the development of better and safer in vitro diagnostics and will offer joint technology solutions for the benefit of users and last but not least also for patients.”

Scienion is based in Berlin with a US subsidiary in Princeton, NJ, and provides systems and services for contact-free printing of biological and chemical agents. Genomica, headquartered in Madrid, develops in vitro diagnostic products and services for genetic identification.

The partners started working together in 2009 and in 2011. Genomica launched array-based tests for sepsis and enteric diseases developed from the collaboration, as GenomeWeb Daily News' sister publication BioArray News previously reported.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more